Los Angeles, CA, United States of America

Ying Qu

This inventor holds 1 USPTO granted patent. Top assignee: Cedars-Sinai Medical Center. Active years: 2024.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Ying Qu. Retrieved from https://idiyas.com/inventor/ying-qu-xh9vv0y4

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 100.0

Average Co-Inventor Count = 4.0

ph-index = 1


Company Filing History:


Years Active: 2024

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Innovations in Stem Cell Research by Inventor Ying Qu

Introduction

Ying Qu is a prominent inventor based in Los Angeles, CA, who has made significant contributions to the field of regenerative medicine. His work focuses on the differentiation of human pluripotent stem cells into mammary-like organoids, which holds great promise for advancements in disease modeling and regenerative therapies.

Latest Patents

Ying Qu holds a patent titled "In vitro induction of mammary-like differentiation from human pluripotent stem cells." This innovative patent describes a reliable two-step protocol for generating human mammary-like organoids from induced pluripotent stem cells (iPSCs). The research demonstrates that iPSCs can be directed in vitro toward mammary lineage differentiation, showcasing the potential for these organoids to express common breast tissue markers and produce milk protein.

Career Highlights

Ying Qu is affiliated with Cedars-Sinai Medical Center, where he continues to advance his research in stem cell technology. His work has been instrumental in understanding the signaling pathways associated with mammary gland function, which could lead to breakthroughs in regenerative medicine.

Collaborations

Ying Qu has collaborated with notable colleagues, including Xiaojiang Cui and Dhruv Sareen, to further enhance the research and development of stem cell applications.

Conclusion

Ying Qu's innovative research and patent contributions are paving the way for new possibilities in regenerative medicine and disease modeling. His work exemplifies the potential of stem cell technology to transform healthcare and improve patient outcomes.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…